{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:55:39Z","timestamp":1784127339696,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hypertension is a major health burden worldwide. However, there is limited data on the status of hypertension-mediated organ damage (HMOD) and established cardiovascular (CV) disease in Chinese hypertensive patients. The aim of this study is to determine the prevalence of HMOD and established CV disease in a nationally representative population in China. A stratified multistage random sampling method was used in the China Hypertension Survey and 21,243 participants aged 35 or older were eligible for analysis in this study. For each participant, the demographic information and a self-reported medical history were acquired. Blood pressure was measured with the electronic device 3 times on the right arm, supported at heart level, after the participant was sitting at rest for 5\u2009min. Samples of blood and urine were tested. 2-D and Doppler echocardiography were used to assess the heart\u2019s function and structures. Sampling weights were calculated based on the 2010 China population census data. Overall, the weighted prevalence of asymptomatic HMOD was 22.1%, 28.9%, 23.1%, 6.4%, and 6.2% for wide pulse pressure, left ventricular hypertrophy, microalbuminuria, chronic kidney disease, and abnormal ankle-brachial index, respectively. For the established CV disease, the weighted prevalence was 1.8%, 1.3%, 2.0%, and 1.1% for stroke, coronary artery disease, heart failure, and atrial fibrillation, respectively. The prevalence of asymptomatic HMOD and established CV disease was greater with higher blood pressure level (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05), rather than ankle-brachial index. Compared to those with uncontrolled hypertension, the prevalence of asymptomatic HMOD was lower in patients with controlled hypertension. In summary, the prevalence of HMOD in Chinese people aged 35 or older was very common, indicating a substantial future burden of both morbidity and mortality from hypertension in China. Clinical trial registration number: ChiCTR-ECS-14004641.<\/jats:p>","DOI":"10.1038\/s41371-021-00635-z","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T14:02:36Z","timestamp":1637330556000},"page":"1092-1098","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Hypertension-mediated organ damage and established cardiovascular disease in patients with hypertension: the China Hypertension Survey, 2012\u20132015"],"prefix":"10.1038","volume":"36","author":[{"given":"Xin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3780-0223","authenticated-orcid":false,"given":"Guang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoqi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Shaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congyi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1613-5076","authenticated-orcid":false,"given":"Zengwu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runlin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,19]]},"reference":[{"key":"635_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(16)31919-5","volume":"389","author":"Collaboration NCDRF.","year":"2017","unstructured":"Collaboration NCDRF. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389:37\u201355.","journal-title":"Lancet."},{"key":"635_CR2","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.117.032380","volume":"137","author":"Z Wang","year":"2018","unstructured":"Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, et al. Status of hypertension in China: results from the China Hypertension Survey, 2012-2015. Circulation. 2018;137:2344\u201356.","journal-title":"Circulation."},{"key":"635_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.aogh.2016.02.002","volume":"82","author":"JD Bundy","year":"2016","unstructured":"Bundy JD, He J. Hypertension and related cardiovascular disease burden in China. Ann Glob Health. 2016;82:227\u201333.","journal-title":"Ann Glob Health"},{"key":"635_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","volume":"385","author":"GBD Mortality","year":"2015","unstructured":"Mortality GBD, Causes of Death C. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117\u201371.","journal-title":"Lancet."},{"key":"635_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5603\/KP.2019.0018","volume":"77","author":"B Williams","year":"2019","unstructured":"Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Kardiol Pol. 2019;77:71\u2013159.","journal-title":"Kardiol Pol"},{"key":"635_CR6","doi-asserted-by":"publisher","first-page":"495349","DOI":"10.4061\/2011\/495349","volume":"2011","author":"RE Katholi","year":"2011","unstructured":"Katholi RE, Couri DM. Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications. Int J Hypertens. 2011;2011:495349.","journal-title":"Int J Hypertens"},{"key":"635_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1161\/01.HYP.0000154082.72286.2a","volume":"45","author":"H Ibsen","year":"2005","unstructured":"Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension. 2005;45:198\u2013202.","journal-title":"Hypertension."},{"key":"635_CR8","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ajh.2008.16","volume":"21","author":"LM Ruilope","year":"2008","unstructured":"Ruilope LM, Schmieder RE. Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens. 2008;21:500\u20138.","journal-title":"Am J Hypertens"},{"key":"635_CR9","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jacc.2014.04.065","volume":"64","author":"JJ Sim","year":"2014","unstructured":"Sim JJ, Shi J, Kovesdy CP, Kalantar-Zadeh K, Jacobsen SJ. Impact of achieved blood pressures on mortality risk and end-stage renal disease among a large, diverse hypertension population. J Am Coll Cardiol. 2014;64:588\u201397.","journal-title":"J Am Coll Cardiol"},{"key":"635_CR10","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ijcard.2014.03.117","volume":"174","author":"Z Wang","year":"2014","unstructured":"Wang Z, Zhang L, Chen Z, Wang X, Shao L, Guo M, et al. Survey on prevalence of hypertension in China: background, aim, method and design. Int J Cardiol. 2014;174:721\u20133.","journal-title":"Int J Cardiol"},{"key":"635_CR11","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/ejhf.1629","volume":"21","author":"G Hao","year":"2019","unstructured":"Hao G, Wang X, Chen Z, Zhang L, Zhang Y, Wei B, et al. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012-2015. Eur J Heart Fail. 2019;21:1329\u201337.","journal-title":"Eur J Heart Fail"},{"key":"635_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ijcard.2018.10.047","volume":"275","author":"Z Wang","year":"2019","unstructured":"Wang Z, Wang X, Hao G, Chen Z, Zhang L, Shao L, et al. A national study of the prevalence and risk factors associated with peripheral arterial disease from China: The China Hypertension Survey, 2012-2015. Int J Cardiol. 2019;275:165\u201370.","journal-title":"Int J Cardiol"},{"key":"635_CR13","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jash.2017.09.004","volume":"11","author":"Z Chen","year":"2017","unstructured":"Chen Z, Wang X, Wang Z, Zhang L, Hao G, Dong Y, et al. Assessing the validity of oscillometric device for blood pressure measurement in a large population-based epidemiologic study. J Am Soc Hypertens. 2017;11:730\u20136.","journal-title":"J Am Soc Hypertens"},{"key":"635_CR14","first-page":"5","volume":"23","author":"B Zhou","year":"2002","unstructured":"Zhou B, Coorperative Meta-Analysis Group Of China Obesity Task F. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Zhonghua Liu Xing Bing Xue Za Zhi. 2002;23:5\u201310.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"635_CR15","first-page":"579","volume":"39","author":"LS Liu","year":"2011","unstructured":"Liu LS, Writing Group of Chinese Guidelines for the Management of H. 2010 Chinese guidelines for the management of hypertension. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39:579\u2013615.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"635_CR16","first-page":"1","volume":"15","author":"Guideline Jcf.","year":"2018","unstructured":"Guideline Jcf. 2016 Chinese guidelines for the management of dyslipidemia in adults. J Geriatr Cardiol. 2018;15:1\u201329.","journal-title":"J Geriatr Cardiol"},{"key":"635_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2054358120944271","volume":"7","author":"RM Holden","year":"2020","unstructured":"Holden RM, Mustafa RA, Alexander RT, Battistella M, Bevilacqua MU, Knoll G, et al. Canadian Society of Nephrology Commentary on the Kidney Disease Improving Global Outcomes 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder. Can J Kidney Health Dis. 2020;7:1\u201323.","journal-title":"Can J Kidney Health Dis"},{"key":"635_CR18","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur J Heart Fail. 2016;18:891\u2013975.","journal-title":"Eur J Heart Fail"},{"key":"635_CR19","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.ejheart.2008.08.005","volume":"10","author":"K Dickstein","year":"2008","unstructured":"Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008;10:933\u201389.","journal-title":"Eur J Heart Fail"},{"key":"635_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2014.03.022","volume":"64","author":"CT January","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr., et al. AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64:1\u201376.","journal-title":"J Am Coll Cardiol"},{"key":"635_CR21","unstructured":"Census Office of The State Council of China, Division of Population and Employment Statistics, National Bureau of Statistics of China. Tabulation on the 2010 population census on the People\u2019s Republic of China. Beijing: China Statistics Press; 2012. http:\/\/www.Stats.Gov.Cn\/tjsj\/pcsj\/rkpc\/6rp\/indexch.htm."},{"key":"635_CR22","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1016\/j.jacc.2008.09.014","volume":"52","author":"DA Bluemke","year":"2008","unstructured":"Bluemke DA, Kronmal RA, Lima JA, Liu K, Olson J, Burke GL, et al. The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol. 2008;52:2148\u201355.","journal-title":"J Am Coll Cardiol"},{"key":"635_CR23","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1001\/jama.292.19.2350","volume":"292","author":"RB Devereux","year":"2004","unstructured":"Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA. 2004;292:2350\u20136.","journal-title":"JAMA."},{"key":"635_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/jhh.2011.104","volume":"26","author":"C Cuspidi","year":"2012","unstructured":"Cuspidi C, Sala C, Negri F, Mancia G, Morganti A, Italian Society of H. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J Hum Hypertens. 2012;26:343\u20139.","journal-title":"J Hum Hypertens"},{"key":"635_CR25","first-page":"21","volume":"125","author":"SX Wang","year":"2012","unstructured":"Wang SX, Xue H, Zou YB, Sun K, Chun-Yan FU, Wang H, et al. Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han Chinese. Chin Med J. 2012;125:21\u20136.","journal-title":"Chin Med J"},{"key":"635_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2261-14-136","volume":"14","author":"H Li","year":"2014","unstructured":"Li H, Pei F, Shao L, Chen J, Sun K, Zhang X, et al. Prevalence and risk factors of abnormal left ventricular geometrical patterns in untreated hypertensive patients. BMC Cardiovasc Disord. 2014;14:1\u20137.","journal-title":"BMC Cardiovasc Disord"},{"key":"635_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1742-1241.2007.01620.x","volume":"62","author":"M Volpe","year":"2008","unstructured":"Volpe M. Microalbuminuria screening in patients with hypertension: recommendations for clinical practice. Int J Clin Pract. 2008;62:97\u2013108.","journal-title":"Int J Clin Pract"},{"key":"635_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00392-007-0510-3","volume":"96","author":"RE Schmieder","year":"2007","unstructured":"Schmieder RE, Schrader J, Zidek W, Tebbe U, Paar WD, Bramlage P, et al. Low-grade albuminuria and cardiovascular risk: what is the evidence? Clin Res Cardiol. 2007;96:247\u201357.","journal-title":"Clin Res Cardiol"},{"key":"635_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1161\/01.CIR.0000133312.96477.48","volume":"110","author":"K Klausen","year":"2004","unstructured":"Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation. 2004;110:32\u20135.","journal-title":"Circulation."},{"key":"635_CR30","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1681\/ASN.2006050517","volume":"17","author":"D Zeeuw","year":"2006","unstructured":"Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol. 2006;17:2100\u20135.","journal-title":"J Am Soc Nephrol"},{"key":"635_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/0003319713513144","volume":"66","author":"G Hao","year":"2015","unstructured":"Hao G, Wang Z, Zhang L, Chen Z, Wang X, Guo M, et al. Prevalence of microalbuminuria among middle-aged population of China: a multiple center cardiovascular epidemiological study. Angiology. 2015;66:49\u201356.","journal-title":"Angiology."},{"key":"635_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2013-003325","volume":"3","author":"J Xiao","year":"2013","unstructured":"Xiao J, Xing X, Lu J, Weng J, Jia W, Ji L, et al. Prevalence and associated factors of microalbuminuria in Chinese individuals without diabetes: cross-sectional study. BMJ Open. 2013;3:1\u201310.","journal-title":"BMJ Open"},{"key":"635_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2369-15-165","volume":"15","author":"L Yan","year":"2014","unstructured":"Yan L, Ma J, Guo X, Tang J, Zhang J, Lu Z, et al. Urinary albumin excretion and prevalence of microalbuminuria in a general Chinese population: a cross-sectional study. BMC Nephrol. 2014;15:1\u20139.","journal-title":"BMC Nephrol"},{"key":"635_CR34","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/ajh.2010.77","volume":"23","author":"MO Ogunniyi","year":"2010","unstructured":"Ogunniyi MO, Croft JB, Greenlund KJ, Giles WH, Mensah GA. Racial\/ethnic differences in microalbuminuria among adults with prehypertension and hypertension: National Health and Nutrition Examination Survey (NHANES), 1999-2006. Am J Hypertens. 2010;23:859\u201364.","journal-title":"Am J Hypertens"},{"key":"635_CR35","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1001\/jamainternmed.2017.4377","volume":"177","author":"R Malhotra","year":"2017","unstructured":"Malhotra R, Nguyen HA, Benavente O, Mete M, Howard BV, Mant J, et al. Association between more intensive vs less intensive blood pressure lowering and risk of mortality in chronic kidney disease stages 3 to 5 a systematic review and meta-analysis. Jama Intern Med. 2017;177:1498\u2013505.","journal-title":"Jama Intern Med"},{"key":"635_CR36","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/01.CIR.100.4.354","volume":"100","author":"SS Franklin","year":"1999","unstructured":"Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation. 1999;100:354\u201360.","journal-title":"Circulation."},{"key":"635_CR37","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1161\/01.HYP.32.3.560","volume":"32","author":"A Benetos","year":"1998","unstructured":"Benetos A, Rudnichi A, Safar M, Guize L. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension. 1998;32:560\u20134.","journal-title":"Hypertension."},{"key":"635_CR38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJMoa1803180","volume":"381","author":"AC Flint","year":"2019","unstructured":"Flint AC, Conell C, Ren X, Banki NM, Chan SL, Rao VA, et al. Effect of systolic and diastolic blood pressure on cardiovascular outcomes. N Engl J Med. 2019;381:243\u201351.","journal-title":"N Engl J Med"},{"key":"635_CR39","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1093\/eurheartj\/ehy287","volume":"39","author":"M Bohm","year":"2018","unstructured":"Bohm M, Schumacher H, Teo KK, Lonn E, Mahfoud F, Mann JFE, et al. Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Eur Heart J. 2018;39:3105\u201314.","journal-title":"Eur Heart J"},{"key":"635_CR40","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.kint.2017.07.002","volume":"92","author":"CM Wyatt","year":"2017","unstructured":"Wyatt CM, Cheung AK. How low can you go? Achieved blood pressure and cardiovascular outcomes. Kidney Int. 2017;92:536\u20139.","journal-title":"Kidney Int"},{"key":"635_CR41","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/jnnp-2016-315346","volume":"88","author":"G Boulouis","year":"2017","unstructured":"Boulouis G, Morotti A, Goldstein JN, Charidimou A. Intensive blood pressure lowering in patients with acute intracerebral haemorrhage: clinical outcomes and haemorrhage expansion. Systematic review and meta-analysis of randomised trials. J Neurol Neurosurg Psychiatry. 2017;88:339\u201345.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"635_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1001293","volume":"9","author":"J Lv","year":"2012","unstructured":"Lv J, Neal B, Ehteshami P, Ninomiya T, Woodward M, Rodgers A, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis. PLoS Med. 2012;9:1\u20139.","journal-title":"PLoS Med"},{"key":"635_CR43","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1161\/HYPERTENSIONAHA.109.139477","volume":"55","author":"JH Skurnick","year":"2010","unstructured":"Skurnick JH, Aladjem M, Aviv A. Sex differences in pulse pressure trends with age are cross-cultural. Hypertension. 2010;55:40\u20137.","journal-title":"Hypertension."}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00635-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00635-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00635-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T11:06:47Z","timestamp":1676286407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00635-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,19]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["635"],"URL":"https:\/\/doi.org\/10.1038\/s41371-021-00635-z","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,19]]},"assertion":[{"value":"27 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethics Committee of Fuwai Cardiovascular Hospital (Beijing, China).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}